Loading…

miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia

Morgana is a ubiquitous HSP90 co-chaperone protein coded by the CHORDC1 gene. Morgana heterozygous mice develop with age a myeloid malignancy resembling human atypical myeloid leukemia (aCML), now renamed MDS/MPN with neutrophilia. Patients affected by this pathology exhibit low Morgana levels in th...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2024-07, Vol.14 (1), p.15089-11, Article 15089
Main Authors: Poggio, Pietro, Rocca, Stefania, Fusella, Federica, Ferretti, Roberta, Ala, Ugo, D’Anna, Flora, Giugliano, Emilia, Panuzzo, Cristina, Fontana, Diletta, Palumbo, Valeria, Carrà, Giovanna, Taverna, Daniela, Gambacorti-Passerini, Carlo, Saglio, Giuseppe, Fava, Carmen, Piazza, Rocco, Morotti, Alessandro, Orso, Francesca, Brancaccio, Mara
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c422t-3bd003db87fcdfe6da9633e3e074927d9cff7d2dfbb01e7ae171796d7ba0dd9e3
container_end_page 11
container_issue 1
container_start_page 15089
container_title Scientific reports
container_volume 14
creator Poggio, Pietro
Rocca, Stefania
Fusella, Federica
Ferretti, Roberta
Ala, Ugo
D’Anna, Flora
Giugliano, Emilia
Panuzzo, Cristina
Fontana, Diletta
Palumbo, Valeria
Carrà, Giovanna
Taverna, Daniela
Gambacorti-Passerini, Carlo
Saglio, Giuseppe
Fava, Carmen
Piazza, Rocco
Morotti, Alessandro
Orso, Francesca
Brancaccio, Mara
description Morgana is a ubiquitous HSP90 co-chaperone protein coded by the CHORDC1 gene. Morgana heterozygous mice develop with age a myeloid malignancy resembling human atypical myeloid leukemia (aCML), now renamed MDS/MPN with neutrophilia. Patients affected by this pathology exhibit low Morgana levels in the bone marrow (BM), suggesting that Morgana downregulation plays a causative role in the human malignancy. A decrease in Morgana expression levels is also evident in the BM of a subgroup of Philadelphia-positive (Ph+) chronic myeloid leukemia (CML) patients showing resistance or an incomplete response to imatinib. Despite the relevance of these data, the mechanism through which Morgana expression is downregulated in patients’ bone marrow remains unclear. In this study, we investigated the possibility that Morgana expression is regulated by miRNAs and we demonstrated that Morgana is under the control of four miRNAs (miR-15a/b and miR-26a/b) and that miR-15a may account for Morgana downregulation in CML patients.
doi_str_mv 10.1038/s41598-024-65404-7
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6c827363c8c04882b2a5e5aa1fda4491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6c827363c8c04882b2a5e5aa1fda4491</doaj_id><sourcerecordid>3074884316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-3bd003db87fcdfe6da9633e3e074927d9cff7d2dfbb01e7ae171796d7ba0dd9e3</originalsourceid><addsrcrecordid>eNp9kUtv1DAURiMEolXpH2CBLLFhE_AzjlcIVUCLikA81taNfTPjIYkHO0Hqv8fTlNKywBtb18fH1_6q6imjLxkV7assmTJtTbmsGyWprPWD6phTqWouOH94Z31Unea8o2UobiQzj6sj0RrVCCOPqw9j-FIzBWSGtME5k3mL5PzrZ0OJi7Xbwh5TnJB8jGkDE5AwEbctleDIeIVDDJ4MuPzAMcCT6lEPQ8bTm_mk-v7u7bez8_ry0_uLszeXtZOcz7XoPKXCd63une-x8WAaIVAg1dJw7Y3re-2577uOMtSATDNtGq87oN4bFCfVxer1EXZ2n8II6cpGCPa6UBq1kObgBrSNa7kWjXCto7JtecdBoQJgvQcpDSuu16trv3QjeofTnGC4J72_M4Wt3cRfljHOKW14Mby4MaT4c8E82zFkh8MAE8YlW0G1Elopowv6_B90F5c0lb86UKU_KVhTKL5SLsWcE_a33TBqD9HbNXpborfX0duD-tndd9we-RN0AcQK5LI1bTD9vfs_2t_garie</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3074884316</pqid></control><display><type>article</type><title>miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Poggio, Pietro ; Rocca, Stefania ; Fusella, Federica ; Ferretti, Roberta ; Ala, Ugo ; D’Anna, Flora ; Giugliano, Emilia ; Panuzzo, Cristina ; Fontana, Diletta ; Palumbo, Valeria ; Carrà, Giovanna ; Taverna, Daniela ; Gambacorti-Passerini, Carlo ; Saglio, Giuseppe ; Fava, Carmen ; Piazza, Rocco ; Morotti, Alessandro ; Orso, Francesca ; Brancaccio, Mara</creator><creatorcontrib>Poggio, Pietro ; Rocca, Stefania ; Fusella, Federica ; Ferretti, Roberta ; Ala, Ugo ; D’Anna, Flora ; Giugliano, Emilia ; Panuzzo, Cristina ; Fontana, Diletta ; Palumbo, Valeria ; Carrà, Giovanna ; Taverna, Daniela ; Gambacorti-Passerini, Carlo ; Saglio, Giuseppe ; Fava, Carmen ; Piazza, Rocco ; Morotti, Alessandro ; Orso, Francesca ; Brancaccio, Mara</creatorcontrib><description>Morgana is a ubiquitous HSP90 co-chaperone protein coded by the CHORDC1 gene. Morgana heterozygous mice develop with age a myeloid malignancy resembling human atypical myeloid leukemia (aCML), now renamed MDS/MPN with neutrophilia. Patients affected by this pathology exhibit low Morgana levels in the bone marrow (BM), suggesting that Morgana downregulation plays a causative role in the human malignancy. A decrease in Morgana expression levels is also evident in the BM of a subgroup of Philadelphia-positive (Ph+) chronic myeloid leukemia (CML) patients showing resistance or an incomplete response to imatinib. Despite the relevance of these data, the mechanism through which Morgana expression is downregulated in patients’ bone marrow remains unclear. In this study, we investigated the possibility that Morgana expression is regulated by miRNAs and we demonstrated that Morgana is under the control of four miRNAs (miR-15a/b and miR-26a/b) and that miR-15a may account for Morgana downregulation in CML patients.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-024-65404-7</identifier><identifier>PMID: 38956394</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/337/384/331 ; 631/67/1990/283/1896 ; 631/80/470/1981 ; Animals ; Apoptosis ; Binding sites ; Bone marrow ; Bone Marrow - metabolism ; Bone Marrow - pathology ; Cancer ; Chronic myeloid leukemia ; Down-Regulation ; Gene Expression Regulation, Leukemic ; Genes ; Hematology ; HSP90 Heat-Shock Proteins - genetics ; HSP90 Heat-Shock Proteins - metabolism ; Hsp90 protein ; Humanities and Social Sciences ; Humans ; Imatinib ; Kinases ; Leukemia ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology ; Malignancy ; Metastasis ; Mice ; MicroRNAs ; MicroRNAs - genetics ; MicroRNAs - metabolism ; Molecular Chaperones - genetics ; Molecular Chaperones - metabolism ; multidisciplinary ; Mutation ; Myelodysplastic syndrome ; Myeloid leukemia ; Neutrophilia ; Proteins ; Science ; Science (multidisciplinary) ; Stem cells ; Tumors</subject><ispartof>Scientific reports, 2024-07, Vol.14 (1), p.15089-11, Article 15089</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c422t-3bd003db87fcdfe6da9633e3e074927d9cff7d2dfbb01e7ae171796d7ba0dd9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3074884316/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3074884316?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38956394$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poggio, Pietro</creatorcontrib><creatorcontrib>Rocca, Stefania</creatorcontrib><creatorcontrib>Fusella, Federica</creatorcontrib><creatorcontrib>Ferretti, Roberta</creatorcontrib><creatorcontrib>Ala, Ugo</creatorcontrib><creatorcontrib>D’Anna, Flora</creatorcontrib><creatorcontrib>Giugliano, Emilia</creatorcontrib><creatorcontrib>Panuzzo, Cristina</creatorcontrib><creatorcontrib>Fontana, Diletta</creatorcontrib><creatorcontrib>Palumbo, Valeria</creatorcontrib><creatorcontrib>Carrà, Giovanna</creatorcontrib><creatorcontrib>Taverna, Daniela</creatorcontrib><creatorcontrib>Gambacorti-Passerini, Carlo</creatorcontrib><creatorcontrib>Saglio, Giuseppe</creatorcontrib><creatorcontrib>Fava, Carmen</creatorcontrib><creatorcontrib>Piazza, Rocco</creatorcontrib><creatorcontrib>Morotti, Alessandro</creatorcontrib><creatorcontrib>Orso, Francesca</creatorcontrib><creatorcontrib>Brancaccio, Mara</creatorcontrib><title>miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Morgana is a ubiquitous HSP90 co-chaperone protein coded by the CHORDC1 gene. Morgana heterozygous mice develop with age a myeloid malignancy resembling human atypical myeloid leukemia (aCML), now renamed MDS/MPN with neutrophilia. Patients affected by this pathology exhibit low Morgana levels in the bone marrow (BM), suggesting that Morgana downregulation plays a causative role in the human malignancy. A decrease in Morgana expression levels is also evident in the BM of a subgroup of Philadelphia-positive (Ph+) chronic myeloid leukemia (CML) patients showing resistance or an incomplete response to imatinib. Despite the relevance of these data, the mechanism through which Morgana expression is downregulated in patients’ bone marrow remains unclear. In this study, we investigated the possibility that Morgana expression is regulated by miRNAs and we demonstrated that Morgana is under the control of four miRNAs (miR-15a/b and miR-26a/b) and that miR-15a may account for Morgana downregulation in CML patients.</description><subject>631/337/384/331</subject><subject>631/67/1990/283/1896</subject><subject>631/80/470/1981</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Binding sites</subject><subject>Bone marrow</subject><subject>Bone Marrow - metabolism</subject><subject>Bone Marrow - pathology</subject><subject>Cancer</subject><subject>Chronic myeloid leukemia</subject><subject>Down-Regulation</subject><subject>Gene Expression Regulation, Leukemic</subject><subject>Genes</subject><subject>Hematology</subject><subject>HSP90 Heat-Shock Proteins - genetics</subject><subject>HSP90 Heat-Shock Proteins - metabolism</subject><subject>Hsp90 protein</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Imatinib</subject><subject>Kinases</subject><subject>Leukemia</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology</subject><subject>Malignancy</subject><subject>Metastasis</subject><subject>Mice</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>Molecular Chaperones - genetics</subject><subject>Molecular Chaperones - metabolism</subject><subject>multidisciplinary</subject><subject>Mutation</subject><subject>Myelodysplastic syndrome</subject><subject>Myeloid leukemia</subject><subject>Neutrophilia</subject><subject>Proteins</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Stem cells</subject><subject>Tumors</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kUtv1DAURiMEolXpH2CBLLFhE_AzjlcIVUCLikA81taNfTPjIYkHO0Hqv8fTlNKywBtb18fH1_6q6imjLxkV7assmTJtTbmsGyWprPWD6phTqWouOH94Z31Unea8o2UobiQzj6sj0RrVCCOPqw9j-FIzBWSGtME5k3mL5PzrZ0OJi7Xbwh5TnJB8jGkDE5AwEbctleDIeIVDDJ4MuPzAMcCT6lEPQ8bTm_mk-v7u7bez8_ry0_uLszeXtZOcz7XoPKXCd63une-x8WAaIVAg1dJw7Y3re-2577uOMtSATDNtGq87oN4bFCfVxer1EXZ2n8II6cpGCPa6UBq1kObgBrSNa7kWjXCto7JtecdBoQJgvQcpDSuu16trv3QjeofTnGC4J72_M4Wt3cRfljHOKW14Mby4MaT4c8E82zFkh8MAE8YlW0G1Elopowv6_B90F5c0lb86UKU_KVhTKL5SLsWcE_a33TBqD9HbNXpborfX0duD-tndd9we-RN0AcQK5LI1bTD9vfs_2t_garie</recordid><startdate>20240702</startdate><enddate>20240702</enddate><creator>Poggio, Pietro</creator><creator>Rocca, Stefania</creator><creator>Fusella, Federica</creator><creator>Ferretti, Roberta</creator><creator>Ala, Ugo</creator><creator>D’Anna, Flora</creator><creator>Giugliano, Emilia</creator><creator>Panuzzo, Cristina</creator><creator>Fontana, Diletta</creator><creator>Palumbo, Valeria</creator><creator>Carrà, Giovanna</creator><creator>Taverna, Daniela</creator><creator>Gambacorti-Passerini, Carlo</creator><creator>Saglio, Giuseppe</creator><creator>Fava, Carmen</creator><creator>Piazza, Rocco</creator><creator>Morotti, Alessandro</creator><creator>Orso, Francesca</creator><creator>Brancaccio, Mara</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240702</creationdate><title>miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia</title><author>Poggio, Pietro ; Rocca, Stefania ; Fusella, Federica ; Ferretti, Roberta ; Ala, Ugo ; D’Anna, Flora ; Giugliano, Emilia ; Panuzzo, Cristina ; Fontana, Diletta ; Palumbo, Valeria ; Carrà, Giovanna ; Taverna, Daniela ; Gambacorti-Passerini, Carlo ; Saglio, Giuseppe ; Fava, Carmen ; Piazza, Rocco ; Morotti, Alessandro ; Orso, Francesca ; Brancaccio, Mara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-3bd003db87fcdfe6da9633e3e074927d9cff7d2dfbb01e7ae171796d7ba0dd9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>631/337/384/331</topic><topic>631/67/1990/283/1896</topic><topic>631/80/470/1981</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Binding sites</topic><topic>Bone marrow</topic><topic>Bone Marrow - metabolism</topic><topic>Bone Marrow - pathology</topic><topic>Cancer</topic><topic>Chronic myeloid leukemia</topic><topic>Down-Regulation</topic><topic>Gene Expression Regulation, Leukemic</topic><topic>Genes</topic><topic>Hematology</topic><topic>HSP90 Heat-Shock Proteins - genetics</topic><topic>HSP90 Heat-Shock Proteins - metabolism</topic><topic>Hsp90 protein</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Imatinib</topic><topic>Kinases</topic><topic>Leukemia</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology</topic><topic>Malignancy</topic><topic>Metastasis</topic><topic>Mice</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>Molecular Chaperones - genetics</topic><topic>Molecular Chaperones - metabolism</topic><topic>multidisciplinary</topic><topic>Mutation</topic><topic>Myelodysplastic syndrome</topic><topic>Myeloid leukemia</topic><topic>Neutrophilia</topic><topic>Proteins</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Stem cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poggio, Pietro</creatorcontrib><creatorcontrib>Rocca, Stefania</creatorcontrib><creatorcontrib>Fusella, Federica</creatorcontrib><creatorcontrib>Ferretti, Roberta</creatorcontrib><creatorcontrib>Ala, Ugo</creatorcontrib><creatorcontrib>D’Anna, Flora</creatorcontrib><creatorcontrib>Giugliano, Emilia</creatorcontrib><creatorcontrib>Panuzzo, Cristina</creatorcontrib><creatorcontrib>Fontana, Diletta</creatorcontrib><creatorcontrib>Palumbo, Valeria</creatorcontrib><creatorcontrib>Carrà, Giovanna</creatorcontrib><creatorcontrib>Taverna, Daniela</creatorcontrib><creatorcontrib>Gambacorti-Passerini, Carlo</creatorcontrib><creatorcontrib>Saglio, Giuseppe</creatorcontrib><creatorcontrib>Fava, Carmen</creatorcontrib><creatorcontrib>Piazza, Rocco</creatorcontrib><creatorcontrib>Morotti, Alessandro</creatorcontrib><creatorcontrib>Orso, Francesca</creatorcontrib><creatorcontrib>Brancaccio, Mara</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poggio, Pietro</au><au>Rocca, Stefania</au><au>Fusella, Federica</au><au>Ferretti, Roberta</au><au>Ala, Ugo</au><au>D’Anna, Flora</au><au>Giugliano, Emilia</au><au>Panuzzo, Cristina</au><au>Fontana, Diletta</au><au>Palumbo, Valeria</au><au>Carrà, Giovanna</au><au>Taverna, Daniela</au><au>Gambacorti-Passerini, Carlo</au><au>Saglio, Giuseppe</au><au>Fava, Carmen</au><au>Piazza, Rocco</au><au>Morotti, Alessandro</au><au>Orso, Francesca</au><au>Brancaccio, Mara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2024-07-02</date><risdate>2024</risdate><volume>14</volume><issue>1</issue><spage>15089</spage><epage>11</epage><pages>15089-11</pages><artnum>15089</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Morgana is a ubiquitous HSP90 co-chaperone protein coded by the CHORDC1 gene. Morgana heterozygous mice develop with age a myeloid malignancy resembling human atypical myeloid leukemia (aCML), now renamed MDS/MPN with neutrophilia. Patients affected by this pathology exhibit low Morgana levels in the bone marrow (BM), suggesting that Morgana downregulation plays a causative role in the human malignancy. A decrease in Morgana expression levels is also evident in the BM of a subgroup of Philadelphia-positive (Ph+) chronic myeloid leukemia (CML) patients showing resistance or an incomplete response to imatinib. Despite the relevance of these data, the mechanism through which Morgana expression is downregulated in patients’ bone marrow remains unclear. In this study, we investigated the possibility that Morgana expression is regulated by miRNAs and we demonstrated that Morgana is under the control of four miRNAs (miR-15a/b and miR-26a/b) and that miR-15a may account for Morgana downregulation in CML patients.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>38956394</pmid><doi>10.1038/s41598-024-65404-7</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2024-07, Vol.14 (1), p.15089-11, Article 15089
issn 2045-2322
2045-2322
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6c827363c8c04882b2a5e5aa1fda4491
source Publicly Available Content (ProQuest); PubMed Central; Free Full-Text Journals in Chemistry; Springer Nature - nature.com Journals - Fully Open Access
subjects 631/337/384/331
631/67/1990/283/1896
631/80/470/1981
Animals
Apoptosis
Binding sites
Bone marrow
Bone Marrow - metabolism
Bone Marrow - pathology
Cancer
Chronic myeloid leukemia
Down-Regulation
Gene Expression Regulation, Leukemic
Genes
Hematology
HSP90 Heat-Shock Proteins - genetics
HSP90 Heat-Shock Proteins - metabolism
Hsp90 protein
Humanities and Social Sciences
Humans
Imatinib
Kinases
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology
Malignancy
Metastasis
Mice
MicroRNAs
MicroRNAs - genetics
MicroRNAs - metabolism
Molecular Chaperones - genetics
Molecular Chaperones - metabolism
multidisciplinary
Mutation
Myelodysplastic syndrome
Myeloid leukemia
Neutrophilia
Proteins
Science
Science (multidisciplinary)
Stem cells
Tumors
title miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A38%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miR-15a%20targets%20the%20HSP90%20co-chaperone%20Morgana%20in%20chronic%20myeloid%20leukemia&rft.jtitle=Scientific%20reports&rft.au=Poggio,%20Pietro&rft.date=2024-07-02&rft.volume=14&rft.issue=1&rft.spage=15089&rft.epage=11&rft.pages=15089-11&rft.artnum=15089&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-024-65404-7&rft_dat=%3Cproquest_doaj_%3E3074884316%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-3bd003db87fcdfe6da9633e3e074927d9cff7d2dfbb01e7ae171796d7ba0dd9e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3074884316&rft_id=info:pmid/38956394&rfr_iscdi=true